| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |